SCHEMBL32667291

SCHEMBL32667291

CCC1(C)CC=C(C)CC1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GLI1 P08151 1/20 0.33
CYP3A4 P08684 1/20 0.33
GLI2 P10070 1/20 0.33
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13863232 0.77 KDM4E (0.30) KDM4ELMNACYP2C19
SCHEMBL19264339 0.76 GLI1 (0.30) GLI1CYP3A4GLI2
SCHEMBL23878722 0.74 GLI1 (0.37) GLI1CYP3A4GLI2
SCHEMBL4837023 0.72
SCHEMBL23465807 0.72
SCHEMBL6752750 0.71 CYP3A4 (0.38) GLI1CYP3A4GLI2LMNA
SCHEMBL25059530 0.71
SCHEMBL22206651 0.71
SCHEMBL18126814 0.70
SCHEMBL1270263 0.68 NR1H3 (0.34) GLI1CYP3A4GLI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092228-A1 COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM VISOLIS INC (US) 2026-04-02 US disclosed
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-04-02 US disclosed
US-20260092130-A1 PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-04-02 US disclosed
US-20260028545-A1 SUSTAINABLE AVIATION FUEL COMPOSITIONS VISOLIS INC (US) 2026-01-29 US disclosed
US-20260028540-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-01-29 US disclosed
US-20260028433-A1 PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND VISOLIS INC (US) 2026-01-29 US disclosed
US-20260028539-A1 COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM VISOLIS INC (US) 2026-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028433-A1 PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND FZD7, WNT1, SFRP1 GLI1 538/4885CYP3A4 568/4885GLI2 1655/4885
US-20260092228-A1 COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM CYP4F12, CYP4F11, CYP4F8 GLI1 502/4885CYP3A4 28/4885GLI2 782/4885
US-20260028540-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND AHR, COASY, YAP1 GLI1 134/4885CYP3A4 34/4885GLI2 357/4885
US-20260092023-A1 PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS CYP4A11, HMGCR, FADS1 GLI1 1028/4885CYP3A4 34/4885GLI2 2136/4885
US-20260092130-A1 PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND SAMM50, MAX, HSF1 GLI1 1043/4885CYP3A4 228/4885GLI2 2901/4885
US-20260028539-A1 COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM CYP4F11, FDFT1, CYP4A11 GLI1 921/4885CYP3A4 33/4885GLI2 2442/4885
US-20260028545-A1 SUSTAINABLE AVIATION FUEL COMPOSITIONS CYP4F12, CYP4F11, CYP4F8 GLI1 193/4885CYP3A4 12/4885GLI2 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.